| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/14/2008 | WO2008045563A9 Modification of ionic strength in antibody-solutions to reduce opalescence/aggregates |
| 08/14/2008 | WO2008034121A3 Parasite vaccine |
| 08/14/2008 | WO2008033500A3 Carbohydrate-based vaccines for hiv |
| 08/14/2008 | WO2007135420A3 Defective interfering virus |
| 08/14/2008 | WO2007117600A3 Combination therapy for treating autoimmune diseases |
| 08/14/2008 | WO2007110700A3 Chlamydial antigens |
| 08/14/2008 | WO2007079351A3 Novel prime-boost combinations of attenuated mycobacterium |
| 08/14/2008 | WO2007075921A3 De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
| 08/14/2008 | WO2006107617A3 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 08/14/2008 | WO2004064783A3 Eosinophil-derived neurotoxin as a marker for ovarian cancer |
| 08/14/2008 | US20080194474 Increasing the population of HSA+/Ly6C+ cells in bone marrow with Fms-like tyrosine kinase 3 ligand (Flt3-Ligand); preventing or delaying type I diabetes, rheumatoid arthritis, lupus, multiple sclerosis, psoriasis, scleroderma, inflammatory bowel diseases, or myasthenia gravis; bone marrow transplant |
| 08/14/2008 | US20080194002 Buffered polyhydroxy hydrocarbon solution comprising adenoviral vector; enhanced stability; gene therapy |
| 08/14/2008 | US20080193971 Using transferrin digestion as tool to generate meningococcal polypeptide products for use in preparing vaccine to prevent or treat meningitis and/or septic shock |
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193546 Solid dose delivery vehicle and methods of making same |
| 08/14/2008 | US20080193535 High speed dissolving dosage form; administering to mucous membrane;matrix containing gelatin, starch and mannitol |
| 08/14/2008 | US20080193515 Overexpression of Wnt ligands and treatment of lytic bone diseases |
| 08/14/2008 | US20080193501 Synergistic; proliferative agents for bone and nervous tissue; can also include an antiinflammatory agent to treat rheumatoid or osteoarthritis; time-release formulations in dosage forms of solutions, gels, pastes or putties |
| 08/14/2008 | US20080193488 Variant Polypeptide and Screening Assay |
| 08/14/2008 | US20080193487 Preparation for Vaccination, Vaccination Method and Use of a Vaccination Preparation |
| 08/14/2008 | US20080193486 Live, Oral Vaccine for Protection Against Shigella Dysenteriae Serotype 1 |
| 08/14/2008 | US20080193485 Dairy products; vaccines; packages |
| 08/14/2008 | US20080193484 Novel Methods for Producing Adenoviral Vector Preparations with Reduced Replication-Competent Adenovirus Contamination and Novel Adenoviral Vectors and Preparations |
| 08/14/2008 | US20080193483 Modified vaccinia Ankara (MVA); replication-deficient strain of vaccinia virus; poxvirus |
| 08/14/2008 | US20080193482 Method of cancer screening; method of cancer treatment; and method of auto-immune disease treatment |
| 08/14/2008 | US20080193481 Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines |
| 08/14/2008 | US20080193480 Infectious Bursal Disease Virus antigenic isolates and vaccines |
| 08/14/2008 | US20080193479 Method and Compositions for the Treatment of Hematologic Cancers |
| 08/14/2008 | US20080193478 Inactivated Poliomyelitis Vaccine Derived From Sabin Strain Of Polio Virus |
| 08/14/2008 | US20080193477 Vaccination Against Dengue Virus Infection |
| 08/14/2008 | US20080193476 Haemophilus influenzae type b (Hib) saccharide conjugates; serotypes; vaccine kits |
| 08/14/2008 | US20080193475 Growing strain of Corynebacterium diphtheria in medium in fermenter under conditions of agitation sufficient to maintain homogenous culture and limited aeration; high yields; prevention of bacterial disease such as C. diphtheriae disease |
| 08/14/2008 | US20080193474 Immunostimulatory Compositions |
| 08/14/2008 | US20080193473 Method for Preparing a Stable Immunogenic Product Comprising Antigenic Heterocomplexes of Tnf Alpha and a Carrier Protein |
| 08/14/2008 | US20080193472 Influenza vaccine formulation |
| 08/14/2008 | US20080193471 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| 08/14/2008 | US20080193470 Proteins and Nucleic Acids from Meningitis/Sepsis-Associated Escherichia Coli |
| 08/14/2008 | US20080193469 Contraceptives Based on Sp22 and Sp22 Antibodies |
| 08/14/2008 | US20080193468 Method for Stimulating the Immune Response of Newborns |
| 08/14/2008 | US20080193467 Dendritic cell potentiation |
| 08/14/2008 | US20080193466 Administering human antibody, or an antigen-binding fragment thereof, to subject, wherein antibody dissociates from human TNF alpha with a Kd of 1x10-8 M or less and a Koff rate constant of 1x10-3 s-1 or or less, and neutralizes human TNF alpha cytotoxicity with an IC50 of 1x10-7 M or less in L929 assay |
| 08/14/2008 | US20080193465 Human Monoclonal Antibodies that Specifically Bind Igf-II |
| 08/14/2008 | US20080193464 Identification of human autism susceptibility gene, which can be used for diagnosis, prevention and treatment of autism; invention discloses that the PRKCB1 gene of chromosome 16 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention |
| 08/14/2008 | US20080193463 Combating the pathogenic effects of Mycoplasma infection in an animal by administering an effective amount of isolated and purified mycoplasmal L-alpha-glycerophosphate oxidase or an immunogenic fragment thereof, and a pharmaceutically acceptable carrier |
| 08/14/2008 | US20080193462 Inhibiting tumor cell growth in subject by administering to said subject a combination of a cytotoxic or a chemotherapeutic agent and a composition comprising an insulin-like growth factor receptor-1 (IGF-1R) inhibitor; demonstrating specific approaches to enhance therapeutic window of IGF-1R inhibition |
| 08/14/2008 | US20080193461 Decreasing tumor growth in a subject in need thereof by detecting an increase in expression of Angiopoietin-1 in the tumor or in the bloodstream and providing radiation to the tumor; includes diagnostic methods for detecting normalization window in tumor vasculature |
| 08/14/2008 | US20080193460 or immunoreactive fragment thereof that binds to the Mu-9 epitope of a colon-specific antigen-p mucin (CSAp) antigen; binds target tissue and conjugate carrying epitope (haptens)l; immunoconjugate; fusion proteins; colon cancer |
| 08/14/2008 | US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies |
| 08/14/2008 | US20080193458 125p5c8: tissue specific protein highly expressed in various cancers |
| 08/14/2008 | US20080193457 Major histocompatibility complex peptide for use in treatment and prevention of rheumatoid arthritis (RA) |
| 08/14/2008 | US20080193456 Glucan conjugated monoclonal antibody for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 08/14/2008 | US20080193455 Placental growth factor (PIGF) specific immunoglobulin for use in treatment and prevention of pathollogical angiogenesis |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193453 Anti Tfr Antibody |
| 08/14/2008 | US20080193452 Sulfated nucleoside derivatives including ribonucleoside mono- and disulfates derived from guanine, adenosine, and cytidine |
| 08/14/2008 | US20080193451 Chimeric, Human and Humanized Anti-CSAP Monoclonal Antibodies |
| 08/14/2008 | US20080193450 Antibodies Against Candida Antigens |
| 08/14/2008 | US20080193449 Antibodies specific for DKK-1 |
| 08/14/2008 | US20080193448 Combinations and Methods of Using an Indolinone Compound |
| 08/14/2008 | US20080193447 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 08/14/2008 | US20080193446 Using monoclonal specific immunoglobulins for treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy |
| 08/14/2008 | US20080193445 Novel anti-IGF-IR antibodies and uses thereof |
| 08/14/2008 | US20080193444 Methods of suppressing LTP inhibition |
| 08/14/2008 | US20080193443 Using connective tissue growth factor specific immunoglobulin for diagnosis, prevention and treatment of autosomal dominant polycystic kidney disease (ADPKD) |
| 08/14/2008 | US20080193442 Inhibition of complement activation |
| 08/14/2008 | US20080193441 Homogeneous Preparations of Chimeric Protein |
| 08/14/2008 | US20080193440 Method For Multiple Sclerosis Treatment and Prophylaxis By Treatment of Leptospira Infection |
| 08/14/2008 | US20080193439 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders |
| 08/14/2008 | US20080193438 Using bioassay comprising phosphatase and tensin homolog (PTEN) elongation factor-2 kinase to identify modulators of phosphatase and tensin homolog (PTEN) activites; treating cell proliferative disorders; antitumor agents |
| 08/14/2008 | US20080193437 Two oligonucleotides each containing 2'-deoxy-7-deazaguanosine and linked by a non-nucleotide linker and where the sequences are at least partially self-complementary; anticarcinogenic agents; antiinflammatory agents; autoimmune diseases; antiallergens asthma; disease; gene therapy; vertabrates |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | US20080193412 Method of Enhancing the Immune Response to a Vaccine |
| 08/14/2008 | US20080193410 Treating warts or verrucae that are induced by papillomavirus; killed mumps virus, candida or trichophyton extract; cytokines or colony stimulating factor |
| 08/14/2008 | US20080193372 Efficacy and Safety of Targeted Particulate Agents with Decoy Systems |
| 08/14/2008 | CA2715045A1 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
| 08/14/2008 | CA2715044A1 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells |
| 08/14/2008 | CA2715042A1 Multivariable antigens complexed with targeting humanized monoclonal antibody |
| 08/14/2008 | CA2678194A1 Anti-human brak (cxcl14) monoclonal antibody and use thereof |
| 08/14/2008 | CA2677799A1 Gnaq mutations in melanoma |
| 08/14/2008 | CA2677455A1 Recombinant antigens of human cytomegalovirus (hcmv) |
| 08/14/2008 | CA2677371A1 Antibodies specific for varicella zoster virus |
| 08/14/2008 | CA2677356A1 Antibodies specific for dkk-1 |
| 08/14/2008 | CA2677244A1 Medicinal agent for treating of avian flu |
| 08/14/2008 | CA2676783A1 Improved methods for producing yeast-based vaccines |
| 08/14/2008 | CA2676036A1 Hepcidin, hepcidin antagonists and methods of use |
| 08/13/2008 | EP1956374A1 Detection and treatment of cancer |
| 08/13/2008 | EP1956094A1 Promoters for expression in modified vaccinia virus ankara |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956085A2 Carbohydrate crosslinked glycoprotein crystals |
| 08/13/2008 | EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/13/2008 | EP1955714A1 Detection and treatment of cancer |
| 08/13/2008 | EP1955709A2 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/13/2008 | EP1955708A1 Novel memory ctl induction potentiator |
| 08/13/2008 | EP1955703A1 Viruses for the treatment of cellular proliferative disorders |
| 08/13/2008 | EP1954720A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 08/13/2008 | EP1954711A2 Chimeric hiv-1 gp120 glycoproteins and their biological applications |
| 08/13/2008 | EP1954312A2 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| 08/13/2008 | EP1954311A2 Ctla-4 antibody dosage escalation regimens |
| 08/13/2008 | EP1954310A2 Method of using il6 antagonists with proteasome inhibitors |